As the patents of many of the top 50 drugs continue to expire over the coming years, the value of companies involved in the manufacture and supply of generic medicines will increase. This fact coupled with a strong business model encouraged Precision to invest in Generic Health Pty Limited as a start up in 2004.
Today, Generic Health is a major supplier of key generic medicines directly to pharmacies and hospitals. Its competitive advantage stems from its niche low cost business model. With over 1500 customers Australia-wide, Generic Health has a team of professionals with significant experience in the area of pharmaceuticals.
The company has entered into supply agreements with foreign manufacturers to supply drugs at globally competitive prices. Generic Health has an emphasis on supply chain integrity based on the extensive experience of its management in the areas of pharmaceutical development, pharmaceutical manufacturing, logistics, quality assurance and the Australian regulatory environment.
The Precision Group recognises the merit of investment in this company both from a financial perspective and for the benefits it brings nationally. Generic pharmaceutical products allow all Australians access to high quality medicine, at a low cost.